What Is Nortriptyline?

Nortriptyline is a tricyclic antidepressant (TCA) that's commonly used at low doses for chronic pain, particularly neuropathic pain. While originally developed for depression, it's been found effective for various pain conditions and often helps with sleep. Brand names include Pamelor and Aventyl.1

How It Works2

  • Blocks reuptake of norepinephrine and serotonin
  • Enhances descending pain inhibition
  • Blocks sodium channels
  • Multiple mechanisms for pain relief
  • Works differently than typical pain relievers

Pain Conditions Treated

  • Diabetic neuropathy
  • Postherpetic neuralgia
  • Migraine prevention
  • Tension headache prevention
  • Fibromyalgia
  • Chronic low back pain
  • Other neuropathic pain

Dosing for Pain3

  • Start low: 10-25 mg at bedtime
  • Increase slowly over weeks
  • Pain doses usually 25-75 mg
  • Lower than antidepressant doses
  • Take at night (helps with sleep)
  • May take 2-4 weeks for effect

Advantages Over Amitriptyline

  • Better tolerated for many
  • Less sedating
  • Fewer anticholinergic effects
  • Often preferred for elderly

Common Side Effects

  • Drowsiness
  • Dry mouth
  • Constipation
  • Weight gain
  • Blurred vision
  • Dizziness
  • Difficulty urinating

Serious Risks

  • Cardiac effects (arrhythmias)
  • Suicidal thoughts (young adults)
  • Serotonin syndrome (with other drugs)
  • Dangerous in overdose
  • Withdrawal if stopped suddenly

Precautions

  • ECG may be needed before starting
  • Caution with heart disease
  • Avoid with glaucoma
  • Caution in elderly
  • May affect blood sugar
  • Don't stop abruptly

Drug Interactions

  • MAO inhibitors (avoid)
  • Other serotonergic drugs
  • CNS depressants
  • Some heart medications
  • Alcohol

What to Expect

  • Side effects often improve with time
  • Pain relief develops gradually
  • May help sleep first
  • Give it adequate trial (6-8 weeks)

References

  1. Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;(7):CD008242.
  2. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173.
  3. Jackson JL, Shimeall W, Sessums L, et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010;341:c5222.